Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Samsung Biologics
Pharma
COINS Act, Hengrui, Samsung Biologics—Fierce Pharma Asia
The Treasury Department closed in on U.S. investments in China life-sci. Hengrui discussed its secret sauce. Samsung Bio averted a strike, for now.
Fraiser Kansteiner
Oct 23, 2026 8:42am
Samsung Bio blunts impact of strike threat with court ruling
Oct 20, 2026 1:40pm
Takeda, Daiichi, Samsung Bio and more—Fierce Pharma Asia
Sep 11, 2026 9:15am
Samsung Bio nets $262M manufacturing deal with unnamed pharma
Sep 10, 2026 7:36am
